Photo by ©Shutterstock.com/Pedro Bento A meta-analysis of smoking cessation therapies, funded by the National Institute on Drug Abuse (NIDA), showed that clinicians should strongly consider varenicline as the first treatment option for women who are trying to quit smoking. Varenicline, a...
©iStockphoto/megaflopp Research funded by the National Institute on Drug Abuse (NIDA) found that patients taking opioids for long-term chronic pain, who were given prescriptions for naloxone in a primary care setting, had 63 percent fewer opioid-related emergency department visits after one year...
Photo by ©iStock.com/shironosov Research funded by the National Institute on Drug Abuse (NIDA) reveals that teaching patients in addiction treatment how to communicate with physicians, and providing training on using an electronic health records portal, empowers them to better engage in their...
Photo by ©iStock.com/18percentgrey New research funded by the National Institute on Drug Abuse (NIDA) found that state implementation of prescription drug monitoring programs (PDMPs) was associated with a reduction in opioid-related overdose deaths. The study, published in Health Affairs, also...
The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, today announced seven recipients of its two Avenir Award programs for HIV/AIDS and genetics or epigenetics research. The awards will support exciting approaches with tools such as genome editing and smart...
Image courtesy of ADAPT Pharma, Inc. Responding to public demand for tools and information to help stem the growing opioid overdose epidemic, the National Institute on Drug Abuse (NIDA) has created a web section dedicated to resources about the opioid overdose reversal drug naloxone. The new web...
Courtesy of Braeburn Pharmaceuticals The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved the first long-acting, subdermal buprenorphine implant for the treatment of opioid...
A project showing how negative attitudes about stress impact key factors that influence vulnerability to addiction, including sleep, emotion and cognition, won a first place Addiction Science Award at the 2016 Intel International Science and Engineering Fair (ISEF)—the world’s largest science...
NIDA hosts research track at APA annual meeting The National Institute on Drug Abuse (NIDA) will present a research track at the 2016 American Psychiatric Association’s (APA’s) Annual Meeting in Atlanta, GA from May 14th through 18th. The NIDA sessions will focus on high priority areas related to...
Dr. Nora Volkow, director of the National Institute on Drug Abuse, part of the National Institutes of Health, will speak about the addicted brain at X-STEM, an Extreme STEM Symposium for middle through high school students on April 14, 2016 in Washington, D.C. X-STEM is a “TED-style” event...